Get your copy of the program and gain expert insights to the specific challenges and solutions in identifying pathogenic B and plasma cell subtypes and therapeutic targets, considerations for clinical trial design and patient stratification, T-cell dependent approaches targeting T & B-cell crosstalk, developing small molecule and biologics approaches targeting B-cell function in autoimmunity at a 2-day, dedicated event.